Structures by: Balasubramanian S.
Total: 74
3-Methoxy-4-(prop-2-yn-1-yloxy)benzaldehyde
C11H10O3
IUCrData (2016) 1, 12 x161919
a=11.8560(6)Å b=11.8836(6)Å c=6.8348(4)Å
α=90.00° β=92.0440(10)° γ=90.00°
C19H14N2O5
C19H14N2O5
Organic letters (2012) 14, 2 552-555
a=9.0334(6)Å b=7.3253(5)Å c=23.9981(15)Å
α=90.00° β=99.161(1)° γ=90.00°
1:1 Cocrystal of Olanzapine and Resorcinol
C17H20N4S,C6H6O2
CrystEngComm (2020)
a=9.3190(5)Å b=11.5430(7)Å c=19.5648(12)Å
α=90° β=90.064(3)° γ=90°
1:1 Cocrystal of Olanzapine and Catechol
C17H20N4S,C6H6O2
CrystEngComm (2020)
a=25.972(5)Å b=9.1477(16)Å c=19.595(4)Å
α=90° β=107.679(8)° γ=90°
1:1:1 Cocrystal of Olanzapine, Hydroquinone and Benzene
C17H20N4S,C6H6O2,C6H6
CrystEngComm (2020)
a=9.0547(18)Å b=10.719(2)Å c=14.236(3)Å
α=80.860(5)° β=82.955(6)° γ=84.355(6)°
1:1:1 Cocrystal of Olanzapine, Hydroquinone and pXylene
C17H20N4S,C6H6O2,C8H10
CrystEngComm (2020)
a=9.3159(3)Å b=10.3802(4)Å c=15.0112(5)Å
α=96.2211(14)° β=90.7786(13)° γ=98.1870(13)°
1:1:2 Cocrystal of Olanzapine, Hydroquinone and Benzene
C17H20N4S,C6H6O2,2(C6H6)
CrystEngComm (2020)
a=9.1116(5)Å b=10.7195(7)Å c=15.8385(9)Å
α=88.452(2)° β=87.7422(17)° γ=82.8273(19)°
1:1:1:2 Cocrystal of Olanzapine, Hydroquinone, pXylene and Water
C17H20N4S,0.5(C6H6O2),0.5(C8H10),2(H2O)
CrystEngComm (2020)
a=28.1714(17)Å b=12.6444(7)Å c=14.0673(8)Å
α=90° β=104.3974(19)° γ=90°
1:1:1 Cocrystal of Olanzapine, Hydroquinone and Ethylbenzene
C17H20N4S,C6H6O2,C8H10
CrystEngComm (2020)
a=9.2694(12)Å b=10.3353(13)Å c=14.9174(19)Å
α=89.159(4)° β=86.632(4)° γ=82.387(4)°
C35H24Cl2NO2P
C35H24Cl2NO2P
Organic & biomolecular chemistry (2020) 18, 7 1354-1358
a=12.8119(3)Å b=20.5439(4)Å c=11.4704(2)Å
α=90° β=101.0819(9)° γ=90°
C40H28N2O2,0.605(CH4O)
C40H28N2O2,0.605(CH4O)
Organic & biomolecular chemistry (2019) 17, 19 4856-4864
a=42.209(4)Å b=10.8705(9)Å c=32.818(3)Å
α=90° β=124.056(3)° γ=90°
C24H21NO2S
C24H21NO2S
Organic & biomolecular chemistry (2019) 17, 24 6015-6024
a=8.1000(10)Å b=9.6228(12)Å c=14.7780(18)Å
α=98.898(2)° β=99.647(2)° γ=113.901(2)°
C25H18O5
C25H18O5
Org. Biomol. Chem. (2017)
a=7.5463(10)Å b=21.489(3)Å c=12.4234(17)Å
α=90° β=105.179(2)° γ=90°
C23H17ClN2S
C23H17ClN2S
Org. Biomol. Chem. (2017)
a=8.3120(5)Å b=10.2393(7)Å c=21.6965(14)Å
α=90° β=97.0530(10)° γ=90°
5-(Tert-butyldimethylsilyloxy)-6-methoxy-1-phenyl-3, 3a, 4, 8b- tetrahydro-1H- indeno [1, 2-c] isoxazole
C23H31NO3Si
Organic & biomolecular chemistry (2014) 12, 16 2552-2558
a=12.368(12)Å b=13.474(14)Å c=13.097(13)Å
α=90.00° β=102.866(17)° γ=90.00°
C20H19ClN4O4
C20H19ClN4O4
New J. Chem. (2015)
a=11.2664(18)Å b=13.069(2)Å c=13.687(2)Å
α=90.00° β=90.327(1)° γ=90.00°
C21H19N3O
C21H19N3O
RSC Advances (2018) 8, 30 16997
a=12.29074(14)Å b=6.54998(8)Å c=21.8593(3)Å
α=90° β=106.2989(5)° γ=90°
Compound1b
{[Mn3(bipy)3(H2O)2][Mn(CN)6]2.2(bipy).2H2O}n
Chemical communications (Cambridge, England) (2017) 53, 36 4907-4910
a=16.039(5)Å b=17.851(4)Å c=11.558(3)Å
α=90° β=90° γ=90°
Compound1
{[Mn3(bipy)3(H2O)4][Mn(CN)6]2.2(bipy).4H2O}n
Chemical communications (Cambridge, England) (2017) 53, 36 4907-4910
a=16.2079(18)Å b=17.833(2)Å c=11.6508(12)Å
α=90° β=90° γ=90°
C32H24FN3O4
C32H24FN3O4
RSC Adv. (2016)
a=10.7757(13)Å b=11.2641(13)Å c=12.0018(14)Å
α=84.249(2)° β=66.118(2)° γ=82.085(2)°
C34H28N2O4
C34H28N2O4
RSC Adv. (2016)
a=10.4245(8)Å b=11.2214(9)Å c=12.1997(10)Å
α=96.489(1)° β=94.707(1)° γ=108.616(1)°
C19H17NO2,0.5(H2O)
C19H17NO2,0.5(H2O)
RSC Adv. (2015)
a=14.3475(11)Å b=11.0883(11)Å c=20.423(2)Å
α=90° β=107.064(2)° γ=90°
C17H17ClN2O
C17H17ClN2O
RSC Adv. (2016)
a=5.479(3)Å b=7.926(4)Å c=18.296(9)Å
α=78.658(8)° β=86.196(8)° γ=79.757(8)°
(E)-N-phenyl-3-(3,4,5-trimethoxystyryl)pyridine-2-amine
C22H22N2O3
RSC Adv. (2015)
a=7.269(3)Å b=7.994(3)Å c=32.597(13)Å
α=90.00° β=96.402(1)° γ=90.00°
[1-(2'-Difluoroboryloxy-4'-methoxyphenyl)-2-(4"-methoxyphenyl)-3- (N,N'-dimethyl)]-2-propen-1-dione
C19H20BF2NO4
Journal of the Chemical Society, Perkin Transactions 1 (2000) 4 567
a=14.056(3)Å b=13.921(3)Å c=18.250(4)Å
α=90.00° β=90.00° γ=90.00°
C30H27Cd2N4O9
C30H27Cd2N4O9
CrystEngComm (2014) 16, 22 4877
a=16.3552(6)Å b=16.0035(6)Å c=12.1024(5)Å
α=90.00° β=111.3990(10)° γ=90.00°
C18H10CdN5O9.5
C18H10CdN5O9.5
CrystEngComm (2014) 16, 22 4877
a=6.7119(7)Å b=24.876(3)Å c=14.0647(17)Å
α=90.00° β=90.00° γ=90.00°
N-(3-phenyl-2-p-tolyl-3,4-dihydroquinazolin-4-yl)benzamide
C28H23N3O
RSC Adv. (2014)
a=10.6039(8)Å b=10.7930(8)Å c=11.0137(8)Å
α=100.245(1)° β=111.738(1)° γ=101.524(1)°
N-(3-phenyl-2-p-tolyl-3,4-dihydroquinazolin-4-yl)acetamide
C23H21N3O
RSC Adv. (2014)
a=9.3171(12)Å b=15.390(2)Å c=13.1098(17)Å
α=90.00° β=92.604(2)° γ=90.00°
Dimethyl 2-(4-tert-butylphenyl)-3-phenyl-3,4-dihydroquinazolin-4-yl phosphonate
C26H29N2O3P
RSC Adv. (2014)
a=14.6985(13)Å b=11.7586(10)Å c=13.8686(12)Å
α=90.00° β=103.257(1)° γ=90.00°
C19H17N3O
C19H17N3O
RSC Adv. (2015)
a=13.2058(10)Å b=5.2630(4)Å c=22.7073(17)Å
α=90.00° β=100.007(10)° γ=90.00°
C17H15NO4
C17H15NO4
RSC Adv. (2014)
a=6.2534(5)Å b=7.7581(7)Å c=15.5349(13)Å
α=90.00° β=91.251(1)° γ=90.00°
C18H17ClO6
C18H17ClO6
RSC Advances (2014)
a=7.9426(11)Å b=8.8414(12)Å c=24.229(3)Å
α=90.00° β=90.00° γ=90.00°
Deferiprone
C7H9NO2
Acta Crystallographica Section C (2020) 76, 2 193-200
a=7.185(3)Å b=12.917(6)Å c=13.697(6)Å
α=90° β=90° γ=90°
Deferiprone
C7H9NO2
Acta Crystallographica Section C (2020) 76, 2 193-200
a=6.48470(10)Å b=13.6853(3)Å c=7.14620(10)Å
α=90° β=95.6583(8)° γ=90°
Deferiprone
C7H9NO2
Acta Crystallographica Section C (2020) 76, 2 193-200
a=19.4132(8)Å b=13.7057(7)Å c=7.1809(7)Å
α=90° β=91.7750(10)° γ=90°
4,4'-{[1,3-Phenylenebis(methylene)]bis(oxy)}bis(3-methoxybenzaldehyde)
C24H22O6
Acta Crystallographica Section E (2019) 75, 6 875-879
a=11.7026(3)Å b=14.6628(4)Å c=12.7512(3)Å
α=90° β=107.863(2)° γ=90°
4,4'-{[(1,4-Phenylenebis(methylene)]bis(oxy)}bis(3-methoxybenzaldehyde)
C24H22O6
Acta Crystallographica Section E (2019) 75, 6 875-879
a=12.6668(5)Å b=7.7470(3)Å c=10.4244(4)Å
α=90° β=102.126(2)° γ=90°
[5,10,15,20-meso-Tetrakis(2-thienyl)porphyrinato-κ^4^N]copper(II)
C36H20CuN4S4
Acta Crystallographica Section E (2001) 57, 8 m346-m348
a=6.5550(2)Å b=10.9180(3)Å c=20.5590(6)Å
α=90.00° β=93.2030(15)° γ=90.00°
2-Acetyl-4-methylphenyl methacrylate
C13H14O3
Acta Crystallographica Section E (2007) 63, 8 o3404-o3404
a=8.4619(3)Å b=8.4810(4)Å c=8.4929(3)Å
α=89.899(2)° β=85.111(3)° γ=76.090(2)°
2-Hydroxy-4-(methacryloyloxy)acetophenone
C12H12O4
Acta Crystallographica Section E (2007) 63, 10 o4163-o4163
a=6.6413(2)Å b=7.2833(3)Å c=12.4387(4)Å
α=84.0200(10)° β=87.447(2)° γ=65.8660(10)°
4,4'-Dimethyl-2,2'-[1,1'-(ethane-1,2-diyldinitrilo)diethylidyne]diphenol
C20H24N2O2
Acta Crystallographica Section E (2007) 63, 11 o4475-o4475
a=18.9118(8)Å b=6.9370(3)Å c=13.4509(5)Å
α=90.00° β=90.00° γ=90.00°
3-Acetyl-4-hydroxyphenyl acrylate
C11H10O4
Acta Crystallographica Section E (2007) 63, 12 o4725-o4725
a=12.3214(16)Å b=6.1103(8)Å c=14.1971(19)Å
α=90.00° β=104.527(3)° γ=90.00°
4'-(4-Methoxyphenyl)-2,2':6',2''-terpyridine
C22H17N3O
Acta Crystallographica Section E (2007) 63, 3 o1148-o1150
a=18.9035(4)Å b=5.16700(10)Å c=17.1558(3)Å
α=90.00° β=90.0690(10)° γ=90.00°
2,3,4,9-Tetrahydro-1<i>H</i>-carbazole
C12H13N
Acta Crystallographica Section E (2008) 64, 12 o2433
a=6.1067(4)Å b=7.9488(5)Å c=19.4512(12)Å
α=90.00° β=90.00° γ=90.00°
3-Acetyl-4-hydroxyphenyl acrylate
C12H12O4
Acta Crystallographica Section E (2009) 65, 9 o2271
a=8.8335(3)Å b=11.9320(3)Å c=11.3295(3)Å
α=90.00° β=111.277(2)° γ=90.00°
<i>c</i>-5-Hydroxy-<i>r</i>-2,<i>c</i>-4-bis(methoxycarbonyl)- <i>t</i>-5-methyl-<i>t</i>-3-(3-nitrophenyl)cyclohexanone
C17H19NO8
Acta Crystallographica Section E (2012) 68, 7 o2213
a=20.1842(18)Å b=5.7380(5)Å c=15.5771(14)Å
α=90.00° β=108.3570(10)° γ=90.00°
5,5,7,12,12,14-Hexamethyl-1,8-bis(4-nitrobenzyl)-1,4,8,11-tetraazacyclotetradecane
C30H46N6O4
Acta Crystallographica Section E (2014) 70, 1 o50
a=8.6407(4)Å b=9.1433(3)Å c=11.0008(5)Å
α=107.742(2)° β=104.898(2)° γ=102.372(2)°
4-(aminosulfonyl)anilinium nitrate
C6H9N2O2S,NO3
Acta Crystallographica Section E (2011) 67, 10 o2788
a=14.1489(19)Å b=8.1786(11)Å c=8.6931(12)Å
α=90.00° β=107.129(2)° γ=90.00°
1-(2-Carboxyethyl)-5-ethyl-2-methylpyridinium chloride
C11H16NO2,Cl
Acta Crystallographica Section E (2012) 68, 10 o2937
a=7.5013(4)Å b=9.0509(5)Å c=9.3452(5)Å
α=75.253(2)° β=80.985(2)° γ=72.047(2)°
Propan-2-yl <i>r</i>-4-(4-fluorophenyl)-3-hydroxy-<i>c</i>-6-methyl-2-phenyl- 4,5-dihydro-2<i>H</i>-indazole-<i>t</i>-5-carboxylate
C24H23FN2O3
Acta Crystallographica Section E (2012) 68, 10 o3021-o3022
a=17.6400(10)Å b=11.0295(6)Å c=11.3791(6)Å
α=90.00° β=99.1330(10)° γ=90.00°
3-Methyl-2-vinylpyridinium phosphate
C8H10N,H2O4P
Acta Crystallographica Section E (2013) 69, 4 o487
a=7.7089(6)Å b=16.3668(13)Å c=8.0649(6)Å
α=90.00° β=109.689(4)° γ=90.00°
Lamotrigine cinnamic acid salt cocrystal
C9H7.34Cl2N5,C9H7.66O2
Crystal Growth & Design (2015) 15, 12 5816
a=17.5729(18)Å b=7.8008(8)Å c=14.8637(15)Å
α=90° β=113.662(2)° γ=90°
Lamotrigine-vanilline cocrystal
C9H7Cl2N5,C8H8O3
Crystal Growth & Design (2015) 15, 12 5816
a=10.7918(9)Å b=13.6805(12)Å c=13.8215(12)Å
α=90° β=110.5040(10)° γ=90°
Lamotriginium-salicylate acetonitrile solvate
C9H8Cl2N5,C7H5O3,C2H3N
Crystal Growth & Design (2015) 15, 12 5816
a=8.8408(5)Å b=10.9916(6)Å c=12.1332(5)Å
α=111.359(4)° β=111.196(5)° γ=93.988(5)°
C12H9N3S
C12H9N3S
The Journal of organic chemistry (2017) 82, 10 5310-5316
a=12.812(2)Å b=7.0885(12)Å c=23.719(4)Å
α=90° β=90° γ=90°
C13H13N3OS
C13H13N3OS
The Journal of organic chemistry (2017) 82, 10 5310-5316
a=7.5226(13)Å b=8.7242(15)Å c=10.8567(19)Å
α=70.464(3)° β=74.325(3)° γ=73.849(3)°
C21H16ClNO2,C2H6O
C21H16ClNO2,C2H6O
The Journal of organic chemistry (2019) 84, 18 12228-12236
a=11.0192(2)Å b=10.5869(2)Å c=17.8709(4)Å
α=90° β=100.0058(9)° γ=90°
C18H18O3
C18H18O3
The Journal of organic chemistry (2018) 83, 24 15361-15371
a=6.4112(12)Å b=8.4234(15)Å c=27.491(5)Å
α=90° β=90° γ=90°
C62H50Fe2N22O5Zn3
C62H50Fe2N22O5Zn3
Inorganic Chemistry (2013) 52, 11385-11397
a=15.8354(5)Å b=17.5204(6)Å c=11.4998(3)Å
α=90.00° β=90.00° γ=90.00°
C24H16Fe2N14O2Zn3
C24H16Fe2N14O2Zn3
Inorganic Chemistry (2013) 52, 11385-11397
a=13.4237(18)Å b=20.496(2)Å c=23.570(4)Å
α=90.00° β=98.472(7)° γ=90.00°
C32H24Fe2N20O6Zn3
C32H24Fe2N20O6Zn3
Inorganic Chemistry (2013) 52, 11385-11397
a=23.1680(17)Å b=7.5344(5)Å c=13.4973(9)Å
α=90.00° β=99.799(5)° γ=90.00°
Zinc(II)-tetra(4-cyanophenyl)porphyrin dinitrophenyl solvate
C48H24N8Zn.2(C6H5NO2)
Inorganic Chemistry (1998) 37, 541-552
a=12.953(3)Å b=9.061(2)Å c=21.131(6)Å
α=90.00° β=102.69(2)° γ=90.00°
Zinc(II)-tetra(4-cyanophenyl)porphyrin anisole solvate
C48H24N8Zn.C7H8O
Inorganic Chemistry (1998) 37, 541-552
a=8.841(6)Å b=11.818(4)Å c=22.079(5)Å
α=87.05(2)° β=89.37(5)° γ=69.62(5)°
Copper(II)-tetra(4-cyanophenyl)porphyrin dichloroform solvate
C48H24N8Cu.2(CHCl3)
Inorganic Chemistry (1998) 37, 541-552
a=9.656(2)Å b=15.111(4)Å c=17.261(3)Å
α=115.36(2)° β=95.510(10)° γ=95.10(2)°
Zinc(II)-tetra(4-cyanophenyl)porphyrin diethylbenzoate solvate
C48H24N8Zn.2(C9H10O2)
Inorganic Chemistry (1998) 37, 541-552
a=11.578(2)Å b=13.579(2)Å c=17.387(5)Å
α=85.17(2)° β=82.09(2)° γ=87.790(10)°
Zinc(II)-tetra(4-cyanophenyl)porphyrin 2.5(anisole) solvate
C48H24N8Zn.2.5(C7H8O)
Inorganic Chemistry (1998) 37, 541-552
a=8.889(2)Å b=11.607(2)Å c=13.647(3)Å
α=94.740(10)° β=96.40(2)° γ=90.27(2)°
Zinc(II)-tetra(4-cyanophenyl)porphyrin tri(guaiacol) solvate
C48H24N8Zn.3(C7H8O2)
Inorganic Chemistry (1998) 37, 541-552
a=8.870(2)Å b=12.406(3)Å c=12.985(2)Å
α=85.89(2)° β=86.91(2)° γ=87.65(2)°
Zinc(II)-tetra(4-nitrophenyl)porphyrin tri(eugenol) solvate
C44H24N8O8Zn.3(C10H12O2)
Inorganic Chemistry (1998) 37, 541-552
a=12.996(3)Å b=16.404(5)Å c=16.673(4)Å
α=110.76(2)° β=99.57(2)° γ=91.19(2)°
Zinc(II)-tetra(4-cyanophenyl)porphyrin chloroform benzene (1:1:1) solvate
C48H24N8Zn.CHCl3.C6H6
Inorganic Chemistry (1998) 37, 541-552
a=9.570(4)Å b=30.037(7)Å c=16.099(6)Å
α=90.00° β=97.71(3)° γ=90.00°
Copper(II)-tetra(4-cyanophenyl)porphyrin dinitrobenzene solvate
C48H24N8Cu.2(C6H5NO2)
Inorganic Chemistry (1998) 37, 541-552
a=13.706(3)Å b=24.138(6)Å c=7.624(3)Å
α=90.00° β=105.78(3)° γ=90.00°
C13H5CdN4O5
C13H5CdN4O5
Inorganic Chemistry (2012) 51, 7103-7111
a=22.382(3)Å b=10.7731(15)Å c=13.5326(18)Å
α=90.00° β=100.108(6)° γ=90.00°